Loading insider details...
Latest Form 4 (Jul 31, 2026): Exercise/Conversion of 21,854 IKT shares, $27.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 31, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Exercise/Conversion | 21,854 | $27.5K |
| Jun 30, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 155,000 | n/a |
| Jul 2, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 108,176 | n/a |
| Feb 20, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 39,620 | n/a |
| Jan 22, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Disposition to Issuer | 21,854 | n/a |
| Jan 7, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 344,452 | n/a |
| Jul 18, 2024 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 30,000 | n/a |
| Jul 6, 2023 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 6,667 | n/a |
| Jun 29, 2022 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 40,000 | n/a |
| Jun 29, 2021 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 22,677 | n/a |